TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications March 18, 1977